Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MSD Escapes Action By UK Competition Body Over Remicade Discount Scheme

Executive Summary

The UK Competition and Markets Authority has announced that there are “no grounds for action” against MSD in relation to a discount scheme the company introduced in England to fend off biosimilar competition for Remicade. But the competition watchdog had some words of warning for other companies considering discount schemes designed to protect a dominant market position.

Advertisement

Related Content

Canadian Authorities Say Janssen Did Not Choke Competition For Infliximab – But Will Keep Spotlight On Originator Abuse Of Power

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel